| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.3 |